Douglas Laurents

Dr. Douglas Laurents

orcid

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 1990 in Biochemistry
Verified
Journal Article
Closed access
CPC. Nick Pace
C. Nick Pace
DLDouglas Laurents
Douglas Laurents
JTJames A. Thomson
James A. Thomson

1 April 2001 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
AHAndrew H. Huber
Andrew H. Huber
DSDaniel B. Stewart
Daniel B. Stewart
DLDouglas Laurents
Douglas Laurents
WNW. James Nelson
W. James Nelson
WWWilliam I. Weis
William I. Weis
Cadherins are single pass transmembrane proteins that mediate Ca2+-dependent homophilic cell-cell adhesion by linking the cytoskeletons of adjacent cells. In adherens junctions, the cytoplasmic domain of cadherins bind to β-catenin, which in turn binds to the actin-associated protein α-catenin. The physical properties of the E-cadherin cytoplasmic domain and its interactions with β-catenin have been investigated. Proteolytic sensitivity, tryptophan fluorescence, circular dichroism, and 1H NMR measurements indicate that murine E-cadherin cytoplasmic domain is unstructured. Upon binding to β-catenin, the domain becomes resistant to proteolysis, suggesting that it structures upon binding. Cadherin-β-catenin complex stability is modestly dependent on ionic strength, indicating that, contrary to previous proposals, the interaction is not dominated by electrostatics. Comparison of 18 cadherin sequences indicates that their cytoplasmic domains are unlikely to be structured in isolation. This analysis also reveals the presence of PEST sequences, motifs associated with ubiquitin/proteosome degradation, that overlap the previously identified β-catenin-binding site. It is proposed that binding of cadherins to β-catenin prevents recognition of degradation signals that are exposed in the unstructured cadherin cytoplasmic domain, favoring a cell surface population of catenin-bound cadherins capable of participating in cell adhesion.

1 March 1989 in Biochemistry
Verified
Journal Article
Closed access
CPC. Nick Pace
C. Nick Pace
DLDouglas Laurents
Douglas Laurents

11 February 2016 in The FEBS Journal
Verified
Journal Article
Closed access
PDF file
MMMiguel Mompeán
Miguel Mompeán
VRValentina Romano
Valentina Romano
DPDavid Pantoja‐Uceda
David Pantoja‐Uceda
CSCristiana Stuani
Cristiana Stuani
FBFrancisco E. Baralle
Francisco E. Baralle
DLDouglas Laurents
Douglas Laurents

1 March 1993 in Current Biology
Verified
Journal Article
Closed access
SSS. Subbiah
S. Subbiah
DLDouglas Laurents
Douglas Laurents
MLM. Levitt
M. Levitt

6 August 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
PGPablo Gracia
Pablo Gracia
DPDavid Polanco
David Polanco
JTJorge Tarancón-Díez
Jorge Tarancón-Díez
ISIlenia Serra
Ilenia Serra
MBMaruan Bracci
Maruan Bracci
NCNunilo Cremades
Nunilo Cremades
Amyloid aggregation of α-synuclein (αS) is the hallmark of Parkinson’s disease and other synucleinopathies. Recently, Tau protein, generally associated with Alzheimer’s disease, has been linked to αS pathology and observed to co-localize in αS-rich disease inclusions, although the molecular mechanisms for the co-aggregation of both proteins remain elusive. We report here that αS phase-separates into liquid condensates by electrostatic complex coacervation with positively charged polypeptides such as Tau. Condensates undergo either fast gelation or coalescence followed by slow amyloid aggregation depending on the affinity of αS for the poly-cation and the rate of valence exhaustion of the condensate network. By combining a set of advanced biophysical techniques, we have been able to characterize αS/Tau liquid-liquid phase separation and identified key factors that lead to the formation of hetero-aggregates containing both proteins in the interior of the liquid protein condensates.